Epigenetic silencing of tumor suppressor candidate 3 confers adverse prognosis in early colorectal cancer
Sign Up to like & getrecommendations! Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.20950
Abstract: Colorectal cancer (CRC) is a biologically and clinically heterogeneous disease. Even though many recurrent genomic alterations have been identified that may characterize distinct subgroups, their biological impact and clinical significance as prognostic indicators remain to… read more here.
Keywords: epigenetic silencing; tumor suppressor; colorectal cancer; crc ... See more keywords